Rating : 10/10 (⭐⭐⭐⭐⭐)
🔹The General Assembly of the German Cancer Society (DKG) has elected Prof. Dr. med. Peter Albers as the new President of the professional society.
🔹The 53-year-old urologist heads the Department of Urology at the University Hospital Düsseldorf and, in addition to his clinical and scientific work, has been actively involved in the German Cancer Society for many years. Before his election as President of the DKG, Albers previously served as Vice President and was the Congress President of the 31st German Cancer Congress in 2012.
🔹Prof. Dr. med. Peter Albers is recognized as a distinguished specialist in urological cancers. For instance, he leads the scientific direction of the PROBASE study on PSA-based early detection in prostate cancer and serves as a co-study leader in the PREFERE study on locally confined prostate cancer.
🔹Additionally, Albers is dedicated to ensuring high-quality care for prostate cancer patients. His clinical research also focuses on testicular tumors and bladder cancer.
🔹2008 – Present: Director of the Department of Urology at the University Hospital Düsseldorf
🔹2003 – 2008: Chief Physician of the Department of Urology at Klinikum Kassel
🔹1994 – 2003: Klinik and Polyclinic for Urology at the University of Bonn
🔹1997: Habilitation
🔹1991 – 1994: Research Associate at the Department of Urology at the University Hospital Mainz and DFG research stay in the USA (Indianapolis)
🔹1988: Doctorate in Medicine
Memberships, Awards, and Involvement:
🔹President of the German Cancer Society from 2016 to 2018
🔹President of the German Cancer Congress in 2012
🔹Past Spokesperson and Board Member of the Working Group on Urological Oncology (AUO) of the German Cancer Society
🔹Spokesperson of the Certification Commission for Prostate Cancer Centers of the German Cancer Society (2008-2016)
🔹Member of the European Organization for Research and Treatment of Cancer (EORTC)
🔹Member of the Scientific Program Committee of the American Society of Clinical Oncology (ASCO) from 2013 to 2016
🔹Member of the Scientific Office of the European Association of Urology (EAU) since 2012
🔹Chairmen of the EAU Testis Cancer Guidelines Group
🔹Member of the International Research Advisory Board of the Movember Foundation (Testis Cancer RAC)
🔹Urological Oncology with a focus on Prostate Cancer
🔹Urothelial Carcinoma
🔹Germ Cell Tumors
🔹Tumor
diseases of the urogenital tract with a focus on prostate cancer, bladder
cancer, renal cell carcinoma, testicular tumors, and penile carcinomas.
🔹Minimal-invasive surgical techniques (since 2010: Da Vinci robot-assisted
techniques for radical prostatectomies, radical cystectomies, organ-preserving
kidney tumor surgery, and urinary tract reconstruction).
🔹Endoscopic surgeries, including laser treatments with modern flexible
instruments for both lower and upper urinary tract.
🔹Stone treatment with intrarenal endoscopic stone therapy.
🔹Andrology in collaboration with the Dermatology Department.
🔹Female and male urinary incontinence within the context of the Pelvic Floor
Center.
